|
1
|
Li D, Gromov K, Søballe K, Puzas JE,
O'Keefe RJ, Awad H, Drissi H and Schwarz EM: Quantitative mouse
model of implant-associated osteomyelitis and the kinetics of
microbial growth, osteolysis, and humoral immunity. J Orthop Res.
26:96–105. 2008. View Article : Google Scholar
|
|
2
|
Farnsworth CW, Schott EM, Benvie AM,
Zukoski J, Kates SL, Schwarz EM, Gill SR, Zuscik MJ and Mooney RA:
Obesity/type 2 diabetes increases inflammation, periosteal reactive
bone formation, and osteolysis during Staphylococcus aureus
implant-associated bone infection. J Orthop Res. 36:1614–1623.
2018. View Article : Google Scholar :
|
|
3
|
Yang Xu CG, Zhou YB, Hao YH, Ren MQ, Wang
YZ, Chen XT, Muhammad JQ, Wang I, Liu SD, et al: Comparative
proteomic analysis provides insight into the key proteins as
possible targets involved in aspirin inhibiting biofilm formation
of staphylococcus xylosus. Front Pharmacol. 8:5432017. View Article : Google Scholar :
|
|
4
|
Cai JY, Hou YN, Li J, Ma K, Yao GD, Liu
WW, Hayashi T, Itoh K, Tashiro SI, Onodera S and Ikejima T:
Prostaglandin E2 attenuates synergistic bactericidal effects
between COX inhibitors and antibiotics on Staphylococcus aureus.
Prostaglandins Leukot Essent Fatty Acids. 133:16–22. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou Y, Wang G, Li Y, Liu Y, Song Y, Zheng
W, Zhang N, Hu X, Yan S and Jia J: In vitro interactions between
aspirin and ampho-tericin B against planktonic cells and biofilm
cells of Candida albicans and C. parapsilosis. Antimicrob Agents
Chemother. 56:3250–3260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sedlacek M, Gemery JM, Cheung AL, Bayer AS
and Remillard BD: Aspirin treatment is associated with a
significantly decreased risk of Staphylococcus aureus bacteremia in
hemodialysis patients with tunneled catheters. Am J Kidney Dis.
49:401–408. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Herrmann K and Flecknell P: Retrospective
review of anesthetic and analgesic regimens used in animal research
proposals. ALTEX. 36:65–80. 2019. View Article : Google Scholar
|
|
8
|
Bethel MA, Harrison P, Sourij H, Sun Y,
Tucker L, Kennedy I, White S, Hill L, Oulhaj A, Coleman RL and
Holman RR: Randomized controlled trial comparing impact on platelet
reactivity of twice-daily with once-daily aspirin in people with
Type 2 diabetes. Diabet Med. 33:224–230. 2016. View Article : Google Scholar
|
|
9
|
Alem MA and Douglas LJ: Prostaglandin
production during growth of Candida albicans biofilms. J Med
Microbiol. 54:1001–1005. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
El-Mowafy SA, Abd El Galil KH, El-Messery
SM and Shaaban MI: Aspirin is an efficient inhibitor of quorum
sensing, virulence and toxins in Pseudomonas aeruginosa. Microb
Pathog. 74:25–32. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Abdelmegeed E and Shaaban MI:
Cyclooxygenase inhibitors reduce biofilm formation and yeast-hypha
conversion of flucon-azole resistant Candida albicans. J Microbiol.
51:598–604. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cattò C, Grazioso G, Dell'Orto S, Gelain
A, Villa S, Marzano V, Vitali A, Villa F, Cappitelli F and Forlani
F: The response of Escherichia coli biofilm to salicylic acid.
Biofouling. 33:235–251. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dotto C, Lombarte Serrat A, Cattelan N,
Barbagelata MS, Yantorno OM, Sordelli DO, Ehling-Schulz M, Grunert
T and Buzzola FR: The active component of aspirin, salicylic acid,
promotes staphylococcus aureus biofilm formation in a PIA-dependent
manner. Front Microbiol. 8:42017. View Article : Google Scholar :
|
|
14
|
Liu Y, Wang L, Kikuiri T, Akiyama K, Chen
C, Xu X, Yang R, Chen W, Wang S and Shi S: Mesenchymal stem
cell-based tissue regeneration is governed by recipient T
lymphocytes via IFN-γ and TNF-α. Nat Med. 17:1594–1601. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cao Y, Xiong J, Mei S, Wang F, Zhao Z,
Wang S and Liu Y: Aspirin promotes bone marrow mesenchymal stem
cell-based calvarial bone regeneration in mini swine. Stem Cell Res
Ther. 6:2102015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lack WD, Fredericks D, Petersen E, Donovan
M, George M, Nepola J, Smucker J and Femino JE: Effect of aspirin
on bone healing in a rabbit ulnar osteotomy model. J Bone Joint
Surg Am. 95:488–496. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dapunt U, Maurer S, Giese T, Gaida MM and
Hänsch GM: The macrophage inflammatory proteins MIP1α (CCL3) and
MIP2α (CXCL2) in implant-associated osteomyelitis: Linking
inflammation to bone degradation. Mediators Inflamm.
2014:7286192014. View Article : Google Scholar
|
|
18
|
Goes R, Muskens IS, Smith TR, Mekary RA,
Broekman MLD and Moojen WA: Risk of aspirin continuation in spinal
surgery: A systematic review and meta-analysis. Spine J.
17:1939–1946. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang C, Wang G, Liu X, Li Y and Sun J:
Safety of continuing aspirin therapy during spinal surgery: A
systematic review and meta-analysis. Medicine (Baltimore).
96:e86032017. View Article : Google Scholar
|
|
20
|
Huang RC, Parvizi J, Hozack WJ, Chen AF
and Austin MS: Aspirin is as effective as and safer than warfarin
for patients at higher risk of venous thromboembolism undergoing
total joint arthroplasty. J Arthroplasty. 31:83–86. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang R, Buckley PS, Scott B, Parvizi J
and Purtill JJ: Administration of aspirin as a prophylaxis agent
against venous thromboembolism results in lower incidence of
periprosthetic joint infection. J Arthroplasty. 30:39–41. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Colleoni JL, Ribeiro FN, Mos PAC, Reis JP,
Oliveira HR and Miura BK: Venous thromboembolism prophylaxis after
total knee arthroplasty (TKA): Aspirin vs. rivaroxaban. Rev Bras
Ortop. 53:22–27. 2017. View Article : Google Scholar
|
